You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
传欧盟与辉瑞及强生等就购买疫苗谈判遇阻
阿思达克 07-28 11:37
《路透社》引述欧盟官员表示,欧盟与辉瑞、赛诺菲及强生等药厂在购买新冠病毒疫苗上,无论在价格、支付方式及潜在责任成本等问题上皆出现分歧。

欧盟此前透露正在与至少6间疫苗生产商进行谈判,希望能预先购买疫苗。不过参与谈判的官员表示,目前很难迅速敲定协议,暂时与强生的谈判是最为深入,但尚未达成协议,双方正在讨论如果潜在疫苗出现意外的副作用,该如何分担责任成本。

据悉,欧盟希望购买赛诺菲与葛兰素史克共3亿剂疫苗,该两药厂希望立即收到整批疫苗的预付款项,但欧盟则希望分批付款,并且希望部分款项在疫苗通过大型临床试验後再付。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account